Millions of dollars.
Thousands of patients.
Jobs.
Company reputation.
Regulatory consequences.
Everything sat beneath the hearing.
Nathan opened a binder.
“Opposing counsel will push you on causation.”
“I know.”
“They'll argue hospital reporting bias.”
“I know.”
“They'll argue your dataset overrepresents severe cases.”
“It does.”
Nathan looked at her.
“You need to say that.”
“I always do.”
He smiled.
“That's why they hate you.”
Simone opened the first exhibit.
At noon, someone knocked.
An assistant entered.
“Dr. Carter, your lunch.”
Simone had forgotten ordering.
She ate half a salad.
At twelve forty, Nathan received a message.
His eyebrows lifted.
“What?”
“Interesting.”
“What?”
“Hartwell's board delegation changed.”
Simone barely cared.
“Why?”
“Company chair isn't attending.”
“Okay.”
“Board sent executive vice president for corporate affairs.”
“Okay.”
Nathan smiled.
“You're wonderfully unimpressed by titles.”
“I work with surgeons.”
He laughed.
Then read the name.
“Vivienne Hart.”
Simone stopped chewing.
Nathan looked up.
“You know her?”
Simone put down the fork.
“No.”
A technically truthful answer for approximately half a second.
Then:
“I met her on the train.”
“How?”
“She accused me of stealing her seat.”
Nathan stared.
Simone drank water.
“I'm sorry.”
“Car number.”
He began laughing.
“Do not.”
“I'm trying.”
“You're failing.”
“Vivienne Hart?”
“Yes.”
“As in daughter of David Hart, founder's family?”
“I didn't ask genealogy during the argument.”
Nathan sat back.
“This is remarkable.”
“It is irrelevant.”
“Probably.”
“That means definitely.”
Nathan smiled.
“Fine.”
Simone returned to her notes.
But something had shifted.
Vivienne Hart.
Hartwell.
Of course.
The surname should have registered.
It hadn't.
Hart was common.
And Simone was not in the habit of researching strangers who yelled at her about train seats.
At one thirty, they left for the hearing.
Federal oversight hearing rooms had a particular atmosphere.
Too cold.
Too bright.
Too much polished wood.
Rows of observers.
Reporters.
Camera crews.
Staff members carrying folders and anxiety.
Simone sat behind a nameplate.
DR. SIMONE CARTER
CHIEF MEDICAL QUALITY OFFICER
MERIDIAN HEALTH SYSTEM
Across the room sat Hartwell's delegation.
Vivienne entered at 1:53.
Burgundy dress.
Gold jewelry.
Hair immaculate.
Same appearance.
Different posture.
She carried a folder.
Spoke quietly to attorneys.
Then looked toward the witness table.
Saw Simone.
Stopped.
No dramatic reaction.
Just a fractional pause.
Then understanding.
Dr. Carter.
The same Dr. Carter.
Simone looked back calmly.
Vivienne sat.
The hearing began.
Opening statements lasted forty-three minutes.
Politicians said words like accountability, innovation, transparency, patient safety, and corporate responsibility.
Some meant them.
Some liked microphones.
Simone listened.
Then she was sworn.
The committee counsel approached.
“Dr. Carter, did your health system identify an unusual pattern associated with Nexaval?”
“Yes.”
“Describe it.”
Simone explained.
Patient outcomes.
Lot numbers.
Time periods.
Manufacturing source.
She avoided conclusions beyond evidence.
“Did every patient receiving the identified lots experience complications?”
“No.”
“Did every complication involve those lots?”
“No.”
“So what made the pattern meaningful?”
“Relative incidence.”
She explained statistical clustering.
The room became quieter.
Simone could turn complicated medicine into plain language without making it inaccurate.
That was why she had been invited.
“Could the pattern have been coincidence?”
“Yes.”
Several Hartwell attorneys looked up.
The committee counsel asked:
“Then why report it?”
“Because possible coincidence is not the same as meaningless observation.”
She continued:
“When serious adverse events cluster around manufacturing identifiers, the proper response is investigation.”
“Did Hartwell investigate?”
Simone paused.
“That is not something I can fully answer from personal knowledge.”
Good.
Careful.
“Did your hospital contact them?”
“Yes.”
“When?”
She gave the date.
“Response?”
“We were told no manufacturing deviation had been identified.”
“Did later documents indicate deviations?”
“Yes.”
An exhibit appeared.
Internal Hartwell production notes.
Temperature fluctuations.
Filtration alarms.
A sterilization interruption.
Vivienne's posture changed.
Simone noticed.
The committee attorney continued.
“Dr. Carter, if Hartwell knew of these irregularities, would they necessarily prove Nexaval was unsafe?”
“No.”
“Would they justify additional review?”
“Yes.”
“Immediate?”
“Yes.”
“How immediate?”
Simone looked toward the committee.
“When a manufacturing irregularity may be associated with serious patient harm, the correct question is not whether you are certain enough to act.”
Silence.
“The question is whether uncertainty is significant enough that failing to act becomes irresponsible.”
Vivienne looked directly at her.
For reasons neither woman understood yet, the train returned to both of them in that moment.
Certainty.
Assumption.
Checking before accusation.
Evidence before conclusion.
Different stakes.
Same intellectual discipline.
The questioning continued.
Hartwell's attorney cross-examined.
“Dr. Carter, you're not a pharmaceutical manufacturing engineer.”
“No.”
“Toxicologist?”
“No.”
“FDA inspector?”
“No.”
“So your testimony concerning manufacturing is limited.”
“Yes.”
The lawyer looked briefly surprised by how easily she conceded.
Simone continued:
“My expertise concerns clinical outcomes and healthcare quality systems.”
“Exactly.”
“Yes.”
“Then you cannot say a production deviation caused any patient's complication.”
“Correct.”
He smiled.
“Thank you.”
Simone waited.
He turned away.
Then she added:
“I can say the association was strong enough that ignoring it without investigation would violate basic quality principles.”
The lawyer stopped.
“Move to strike as nonresponsive.”
The chair allowed the answer.
Vivienne looked down.
The hearing lasted four hours.
No dramatic confession.
No executive dragged away.
Real accountability rarely behaved like television.
Documents were entered.
Witnesses disagreed.
Lawyers objected.
Committee members made speeches.
By six ten, Simone was exhausted.
She left through a side corridor.
Nathan followed.
“You were good.”
“I answered questions.”
“You ruined three carefully constructed arguments.”
“Those were bad arguments.”
“That is what ruining them means.”
They reached the elevator.
Doors opened.
Vivienne was inside.
Alone.
Nathan looked from one woman to the other.
Simone considered waiting.
Vivienne stepped backward.
“There is room.”
Nathan smiled too enthusiastically.
“I'll take the next one.”